Schriftenverzeichnis KJP 2011 Gesamt-IF: 137,284
1. Biehl SC, Dresler T, Reif A, Scheuerpflug P, Deckert J, Herrmann MJ (2011)
Dopamine transporter (DAT1) and dopamine receptor D4 (DRD4) genotypes differential y impact on electrophysiological correlates of error processing. PloS ONE 6:12 e28396 (IF 4,092)
2. Chen Y, Palm F, Lesch KP, Gerlach M, Moessner R, Sommer C (2011) 5-Hydro-
xyindolacetic acid (5-HIAA), a main metabolite of serotonin, is responsible for complete Freund's adjuvant-induced thermal hyperalgesia in mice. Mol Pain 7:21 (IF 3,526)
3. Egberts K, Mehler-Wex C, Gerlach M (2011) Therapeutic drug monitoring in child
and adolescent psychiatry. Pharmacopsychiatry 44:249-53 (IF 2,071)
4. Ehlis AC, Bauernschmitt K, Dresler T, Hahn T, Herrmann MJ, Röser C, Romanos
M, Warnke A, Gerlach M, Lesch KP, Fal gatter AJ, Renner TJ (2011) Influence of a genetic variant of the neuronal growth associated protein Stathmin 1 on cognitive and affective control processes: An event-related potential study. Am J Med Genet B Neuropsychiatr Genet 156:291-302 (IF 3,705)
5. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, Sleiman PM,
Zhang H, Kim CE, Robison R, Lyon GJ, Flory JH, Bradfield JP, Imielinski M, Hou C, Frackelton EC, Chiavacci RM, Sakurai T, Rabin C, Middleton FA, Thomas KA, Garris M, Mentch F, Freitag CM, Steinhausen HC, Todorov AA, Reif A, Rothenberger A, Franke B, Mick EO, Roeyers H, Buitelaar J, Lesch KP, Banaschewski T, Ebstein RP, Mulas F, Oades RD, Sergeant J, Sonuga-Barke E, Renner TJ, Romanos M, Romanos J, Warnke A, Walitza S, Meyer J, Pálmason H, Seitz C, Loo SK, Smal ey SL, Biederman J, Kent L, Asherson P, Anney RJ, Gaynor JW, Shaw P, Devoto M, White PS, Grant SF, Buxbaum JD, Rapoport JL, Wil iams NM, Nelson SF, Faraone SV, Hakonarson H (2011) Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet. 4:78-84 (IF 35,532)
6. Föcker M, Timmesfeld N, Scherag S, Bühren K, Langkamp M, Dempfle A,
Sheridan EM, de Zwaan M, Fleischhaker C, Herzog W, Egberts K, Zipfel S, Her- pertz-Dahlmann B, Hebebrand J (2011) Screening for anorexia nervosa via mea- surement of serum leptin levels. J Neural Transm 118: 571-8 (IF 2,730)
7. Geis Ch, Weishaupt A, Grünewald B, Wultsch T, Reif A, Gerlach M, Dirkx R,
Solimena M, Perani D, Heckmann M, Toyka KV, Fol i F, Sommer C (2011) Human Stiff-person syndrome IgG induces anxious behavior in rats. PloS ONE 6:2 e16775 (IF 4,411)
8. Gerlach M, Bartoszyk GD, Riederer P, Dean O, van den Buuse M (2011) Role of
dopamine D3 receptors and serotonin 5-HT1A receptors in levodopa-induced dys- kinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson´s disease. J Neural Transm 118:1733-42 (IF 2,730)
9. Gerlach M, Baas H, Jost W, Klucken J, Riederer P (2011) Nutzen von Pharma-
kokinetik- und Pharmakogenetik - Wissen für die Parkinson-Therapie. Akt Neurol: 38:544-8 (IF 0,318)
10. Gerlach M, Beck J, Riederer P, van den Buuse (2011) Flibanserin attenuates L-
DOPA-sensitized contraversive circling in the unilateral y 6-hydroxydopamine- lesioned rat model of Parkinson´s disease. J Neural Transm 118:1727-32 (IF 2,730)
11. Gerlach M, Riederer P, Schel er D (2011) Ediorial. Mechanisms underlying and
medical management of L-DOPA-associated motor complications. J Neural Transm 118:1659-60 (IF 2,730)
12. Grünblatt E, Schmidt WJ, Schel er DKA, Riederer P, Gerlach M (2011) Trans-
criptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats. J Neural Transm 118:1717-25 (IF 2,730)
13. Hansen N, Üçeyler N, Palm F, Zelenka M, Biko L, Lesch KP, Gerlach M, Sommer
C (2011) Lack of the serotonin transporter protects mice from mechanical al odynia and heat hyperalgesia in vincristine neuropathy. Neurosci Lett 495:93 - 7 (IF 2,105)
14. Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M,
Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Mül er MJ, Pfuhlmann B,
Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G (2011) The TDM group of the AGNP (2011) AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update. Pharmaco- psychiatry 44:195-235 (IF 2,071)
15. Hinney A, Scherag A, Jarick I, Albayrak Ö, Pütter C, Pechlivanis S, Dauvermann
MR, Beck S, Weber H, Scherag S, Nguyen TT, Volckmar AL, Knol N, Faraone SV, Neale BM, Franke B, Cichon S, Hoffmann P, Nöthen MM, Schreiber S, Jöckel KH, Wichmann HE, Freitag C, Lempp T, Meyer J, Gilsbach S, Herpertz-Dahlmann B, Sinzig J, Lehmkuhl G, Renner TJ, Warnke A, Romanos M, Lesch KP, Reif A, Schimmelmann BG, Hebebrand J (2011) Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Psychiatric GWAS Consortium: ADHD subgroup. Am J Med Genet B Neuropsychiatr Genet 156:888- 97 (IF 3,526)
16. Jans T, Bal J, Preiss M, Haberhausen M, Warnke A, Renner TJ (2011) Pervasive
Refusal Syndrome – three German Cases provide further il ustration. Z Kinder Jugendpsychiatr Psychother 36: 45-52 (IF 0,986)
17. Koelch M, Pfalzer AK, Kliegl K, Rothenhöfer S, Ludolph AG, Fegert JM, Burger R,
Mehler-Wex C, Stingl J, Taurines R, Egberts K, Gerlach M (2012) Therapeutic drug monitoring of children and adolescents treated with fluoxetine. Pharmaco- psychiatry 45:72 – 6 (IF 2,071)
18. König IR, Schumacher J, Hoffmann P, Kleensang A, Ludwig KU, Grimm T,
Neuhoff N, Preis M, Roeske D, Warnke A, Propping P, Remschmidt H, Nöthen MM,Ziegler A, Mül er-Myhsok B, Schulte-Körne G (2011) Mapping for dyslexia and related cognitive trait loci provides strong evidence for further risk genes on chromosome 6p21. Am J Med Genet B Neuropsychiatr Genet. Jan; 156:36-43 (IF 3,526)
19. Matsson H, Tammimies K, Zucchel i M, Anthoni H, Onkamo P, Nopola-Hemmi J,
Lyytinen H, Leppanen PH, Neuhoff N, Warnke A, Schulte-Körne G, Schumacher J, Nöthen MM, Kere J, Peyrard-Janvid M (2011) SNP variations in the 7q33 region containing DGKI are associated with dyslexia in the Finnish and German populations. Behav Genet 41:134 - 40 (IF 2,520)
20. Meister L, Alawam K, Dudley E, Taurines R, Mül er SE, Walter M, Höppner J,
Teipel S, Donev RM, Eckert A, Wiesbeck GA, Thome J (2011) Pilot study of the
application of magnetic bead protein profiling to the study of biomarkers in addiction research. World J Biol Psychiatry 12 [Suppl 1]:80-4 (IF 2,385)
21. Melfsen S, Kuehnemund M, Schwieger J, Warnke A, Stadler C, Poustka F,
Staniger U (2011) Cognitive behavioral therapy of social y phobic children focu-sing on cognition: a randomised wait-list control study. CAPMH 5 (DOI:10.1186/ 1753-2000-5-5)
22. Melfsen S, Walitza S, Warnke A (2011) Psychometrische Eigenschaften und
Normierung des Sozialphobie und –angstinventars für Kinder (SPAIK) an einer klinischen Stichprobe. Z Kinder Jugendpsychiatr Psychother 39:399-407 (IF 0,986)
23. Mül er TD, Tschöp MH, Jarick I, Ehrlich S, Scherag S, Herpertz-Dahlmann B,
Zipfel S, Herzog W, de Zwaan M, Burghardt R, Fleischhaker C, Klampfl K, Wewetzer C, Herpertz S, Zeeck A, Tagay S, Burgmer M, Pfluger PT, Scherag A, Hebebrand J, Hinney A (2011) Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa. J Psych Res 45:706-11 (IF 4,664))
24. Oberländer U, Pletinckx K, Döhler A, Mül er N, Lutz MB, Arzberger T, Riederer P,
Gerlach M, Koutsilieri E, Schel er C (2011) Neuromelanin is an immune stimulator for dendritic cel s in vitro. BMC Neuroscience 12:116 (IF 3,042)
25. Reif A, Nguyen TT, Weißflog L, Jacob CP, Romanos M, Renner TJ, Buttenschon
HN, Kittel-Schneider S, Gessner A, Weber H, Neuner M, Gross-Lesch S, Zamzow K, Kreiker S, Walitza S, Meyer J, Freitag CM, Bosch R, Casas M, Gómez N, Ribasès M, Bayès M, Buitelaar JK, Kiemeney LA, Kooij JJ, Kan CC, Hoogman M, Johansson S, Jacobsen KK, Knappskog PM, Fasmer OB, Asherson P, Warnke A, Grabe HJ, Mahler J, Teumer A, Völzke H, Mors ON, Schäfer H, Ramos-Quiroga JA, Cormand B, Haavik J, Franke B, Lesch KP (2011) DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders. Neuropsychopharma- cology 36:2318-27 (IF 7,991)
26. Renner TJ, Nguyen TT, Romanos M, Dempfle A, Walitza S, Röser C, Reif A,
Schäfer H, Warnke A, Gerlach M, Lesch KP (2011) No evidence for association between a functional promoter variant of the noradrenaline transporter gene SLC6A2 and ADHD in a family based sample. ADHD Attent Def Hyp Disord 3: 285 - 9
27. Romanos M, Buske-Kirschbaum A, Fölster-Holst R, Weidinger S, Gerlach M,
Schmitt J (2011) Itches and scratches – is there a link between attention- deficit/hyperactivity disorder, atopic eczema, sleep disruption and food hyper– sensitivity? Al ergy 66: 1407-11 (IF 6,271)
28. Romanos M, Schecklmann M, Kraus K, Fal gatter AJ, Warnke A, Lesch KP,
Gerlach M (2011) Letter to the editor. Olfactory deficits in deletion syndrome 22q11.2. Schizophrenia Res 129:220-21 (IF 4,748)
29. Schecklmann M, Schaldecker M, Aucktor S, Brast J, Kirchgassner K, Mühlberger
A, Warnke A, Gerlach M, Fal gatter AJ, Romanos M (2011) Effect of methyl- phenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD. J Psych Res 45:1463-70 (IF 4,664)
30. Schmitt J, Chen C M, Apfelbacher C, Romanos M, Lehmann I, Herbarth O,
Schaaf B, Kraemer U, von Berg A, Wichmann HE, Heinrich J (2011) Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISAplus. Al ergy 66: 404-11 (IF 6,271)
31. Schwenck C, Schmitt D, Sievers S, Romanos M, Warnke A, Schneider W (2011)
Cognitive and emotional empathy in children with ADHD and conduct disorder. Z Kinder Jugendpsychiatr 39: 265-76 (IF 0,986)
32. Slof-Op 't Landt MCT, Meulenbelt I, Bartels M, Suchiman E, Middeldorp CM,
Houwing-Duistermaat JJ, van Trier J, Onkenhout EJ, Vink JM, van Beijsterveldt CE, Brandys MK, Sanders N, Zipfel S, Herzog W, Herpertz-Dahlmann B, Klampfl K, Fleischhaker C, Zeeck A, de Zwaan M, Herpertz S, Ehrlich S, van Elburg AA, Adan RA, Scherag S, Hinney A, Hebebrand J, Boomsma DI, van Furth EF, Slagboom PE (2011) Association study in eating disorders: TPH2 associates with anorexia nervosa and self-induced vomiting. Genes Brain Behav 10:236-43 (IF 3,476)
33. Taurines R, Gerlach M, Warnke A, Thome J, Wewetzer C (2011) Pharmacothe-
rapy in depressed children and adolescents. World J Biol Psychiatry 12 [Suppl 1]:11-5 (IF 2,385)
34. Taurines R, Grünblatt E, Schecklmann M, Schwenck C, Albantakis L, Reef-
schläger L, Walitza S, Renner TJ, Gerlach M, Thome J, Romanos M (2011) Altered mRNA expression of monoaminergic candidate genes in the blood of
children with attention deficit hyperactivity disorder and autism spectrum disorder. World J Biol Psychiatry [Suppl 1]:104-8 (IF 2,385)
35. Walitza S, Melfsen S, Jans T, Zel mann H, Wewetzer C, Warnke A (2011) Review
article: Obsessive-Compulsive Disorder in Children and Adolescents. Dtsch Arztebl Int 108:173-9 (IF 2,920)
PHYSICIAN'S MEDICAL REPORT Protected when completed. Your patient has been selected to be part of a Government of Canada (GoC) overseas event. The schedule of events is usually quite demanding for which delegates must meet certain requirements in physical capacity. Furthermore, air travel generally induces a certain degree of arterial oxygen desaturation which may
KEY SKILLS COMMUNICATION Level 3 – Drinking Water [KSC3Mr4] Source Booklet Tuesday 23 March 2004 • This booklet contains source material for the Level 3 Communication test, March 2004• The test questions will be based on this material• You must hand in this Source Booklet at the end of the test, along with your The Level 3 Communication test will assess your abili